Related Experiment Video
Updated: Jan 27, 2026

13:42
Clinical Examination Protocol to Detect Atypical and Classical Scrapie in Sheep
Published on: January 19, 2014
14.0K
Chorea, Pruritus and Polycythemia: Looking for Clues.
Vânia Rodrigues1, Carolina Lopes2, Adilson Marcolino2
1Internal Medicine Department, Centro Hospitalar de Leiria, Leiria, Portugal.
European Journal of Case Reports in Internal Medicine
|April 2, 2019
Summary
Polycythemia vera (PV) can cause chorea, a rare movement disorder. Prompt diagnosis and treatment of PV, a myeloproliferative disorder, can lead to chorea resolution, especially in elderly women.
Area of Science:
- Neurology
- Hematology
- Genetics
Background:
- Chorea is a movement disorder with diverse etiologies, including vascular, hereditary, metabolic, and drug-induced causes.
- Polycythemia vera (PV) is an uncommon cause of chorea, predominantly affecting elderly women.
- Identifying PV as a cause of chorea is crucial as it is a treatable condition.
Purpose of the Study:
- To report a case of chorea secondary to polycythemia vera in an elderly woman.
- To highlight the importance of considering PV in the differential diagnosis of chorea in the elderly.
- To demonstrate the efficacy of PV treatment in resolving chorea.
Main Methods:
- Case report of a 75-year-old woman presenting with chorea.
- Hematological evaluation revealing attributes of PV.
- Genetic testing for Janus Kinase 2 (JAK2) gene mutation.
- Treatment with hydroxyurea.
Main Results:
- The patient exhibited involuntary movements characteristic of chorea.
- Hematological findings confirmed PV with a JAK2 mutation.
- Treatment with hydroxyurea resulted in significant reduction of chorea symptoms.
- Improvement in hematological parameters was observed post-treatment.
Conclusions:
- Polycythemia vera is a treatable myeloproliferative disorder that can cause chorea.
- Early diagnosis and management of PV are essential for chorea resolution.
- Treatment strategies for PV include hydroxyurea for high-risk cases and aspirin/phlebotomy for low-risk cases.

